StockpollyBeta
Get App
Delisting riskPopularity #4,982Earnings today
BRTX · NASDAQ · Biotechnology

BioRestorative Therapies (BRTX)

Develops autologous cell therapies and cell-secretome cosmetics for spine and metabolic applications.

$2.62
After hours−0.05 (−1.87%)
At close$2.67(−1.48%)

In millions of USD, except per-share figures

In millionsQ2 FY23Jun 2023Q3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026
Revenue000000000000
Cost of revenue000000000000
Gross profit000000000000
333433354443
Research & development111111222332
223311131111
Selling & marketing000000000000
General & administrative223311131111
Operating income−3−3−3−4−2−2−3−5−3−4−4−3
−3842−211−11111
Interest income000000000000
Interest expense000000000000
Other non-operating income30−5−22−1−11−1−1−1−1
Income before tax−651−2−4−1−2−5−3−3−3−2
Net income from continuing operations−651−2−4−1−2−5−3−3−3−2
Net income−651−2−4−1−2−5−3−3−3−2
EPS, basic−$1.47$1.04$5.00−$6.60−$10.00−$2.60−$4.80−$12.80−$6.00−$6.60−$7.20−$2.40
EPS, diluted−$1.47$1.04$5.00−$6.60−$10.00−$2.60−$4.80−$12.80−$6.00−$6.60−$7.20−$2.40
Weighted average shares, basic450000000001
Weighted average shares, diluted450000000001
EBITDA−6−31−2−4−1−2−5−3−3−3−2
Depreciation & amortization000000000000
EBIT−6−31−2−4−1−2−5−3−3−3−2